skip to main content

BSC – SEM 3 UNIT 6 PHARMACOLOGY

UNIT-6- Drugs used in treatment of endocrine system disorders

Drugs Used in the Treatment of Endocrine System Disorders: Introduction

1. Introduction

The endocrine system consists of glands that produce hormones to regulate metabolism, growth, development, and homeostasis. Disorders occur due to hormonal excess, deficiency, or dysfunction, requiring pharmacological intervention to restore balance.

Drugs used for endocrine disorders either:

  • Replace deficient hormones (e.g., insulin for diabetes, levothyroxine for hypothyroidism).
  • Suppress excessive hormone production (e.g., methimazole for hyperthyroidism, corticosteroids for adrenal hyperactivity).
  • Modify hormone effects (e.g., oral antidiabetics, growth hormone inhibitors).

2. Major Endocrine Glands & Their Disorders

GlandHormoneDisorders
Pituitary GlandGrowth Hormone (GH), ADH, ACTHGigantism, Acromegaly, Diabetes Insipidus
Thyroid GlandThyroxine (T₄), Triiodothyronine (T₃), CalcitoninHypothyroidism, Hyperthyroidism, Goiter
Parathyroid GlandParathyroid Hormone (PTH)Hypoparathyroidism, Hyperparathyroidism
Adrenal GlandsCortisol, Aldosterone, EpinephrineAddison’s Disease, Cushing’s Syndrome, Pheochromocytoma
PancreasInsulin, GlucagonDiabetes Mellitus (Type 1 & Type 2)
Ovaries/TestesEstrogen, Progesterone, TestosteronePCOS, Hypogonadism, Menopause

3. General Classification of Drugs for Endocrine Disorders

CategoryExamplesIndications
1. Hormone Replacement TherapyInsulin, Levothyroxine, HydrocortisoneDiabetes, Hypothyroidism, Addison’s Disease
2. Antithyroid DrugsMethimazole, Propylthiouracil (PTU)Hyperthyroidism
3. Oral HypoglycemicsMetformin, SulfonylureasType 2 Diabetes
4. GlucocorticoidsPrednisone, DexamethasoneInflammation, Addison’s Disease
5. MineralocorticoidsFludrocortisoneAddison’s Disease
6. Parathyroid ModulatorsCalcitriol, CinacalcetHypoparathyroidism, Hyperparathyroidism
7. Growth Hormone TherapySomatropin, OctreotideGrowth Disorders (Dwarfism, Acromegaly)
8. Sex Hormones & AntagonistsEstrogen, Testosterone, TamoxifenMenopause, Hypogonadism, PCOS, Breast Cancer

4. Importance of These Drugs

  • Restore normal hormone levels to prevent complications.
  • Improve metabolism, growth, and reproduction.
  • Prevent long-term complications like heart disease, osteoporosis, and nerve damage in diabetes.

Insulin & Oral Hypoglycemics:

1. Introduction

Insulin and oral hypoglycemic agents are used to control blood glucose levels in patients with diabetes mellitus. They help prevent complications such as diabetic ketoacidosis (DKA), neuropathy, retinopathy, nephropathy, and cardiovascular diseases.


2. Insulin

A. Composition of Insulin

Insulin is a polypeptide hormone produced by the beta cells of the pancreas. The main types of insulin used in therapy include:

  • Human Insulin (Recombinant DNA technology)
  • Analog Insulin (Modified human insulin for better absorption and effect)

B. Types of Insulin & Their Action

TypeExamplesOnsetPeakDuration
Rapid-ActingLispro, Aspart, Glulisine10-30 min1-2 hrs3-5 hrs
Short-ActingRegular Insulin (Humulin R, Actrapid)30-60 min2-4 hrs5-8 hrs
Intermediate-ActingNPH (Humulin N, Insulatard)1-2 hrs6-12 hrs12-18 hrs
Long-ActingGlargine, Detemir, Degludec1-2 hrsNo peak24-42 hrs
Premixed70/30 (NPH/Regular), 50/50, 75/25VariesDual peak10-24 hrs

C. Dosage & Route

  • Dosage: Individualized based on blood glucose levels, insulin sensitivity, and lifestyle.
  • Route: Subcutaneous (SC) (most common), Intravenous (IV) (only regular insulin in emergencies like DKA).
  • Administration Sites: Abdomen, thighs, buttocks, upper arms.

D. Indications

  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus (when oral drugs are ineffective)
  • Gestational Diabetes
  • Diabetic Ketoacidosis (DKA)
  • Hyperosmolar Hyperglycemic State (HHS)
  • Perioperative & Critically Ill Patients (Blood glucose control)

E. Contraindications

  • Hypoglycemia
  • Allergy to insulin or preservatives
  • Severe hypokalemia (risk of cardiac arrhythmia)

F. Drug Interactions

Interacting DrugEffect
Beta-BlockersMask symptoms of hypoglycemia
CorticosteroidsIncrease blood glucose, reducing insulin effect
Oral HypoglycemicsRisk of hypoglycemia when combined
Thiazide DiureticsIncrease blood glucose, reducing insulin effectiveness

G. Side Effects

  • Hypoglycemia (sweating, tremors, dizziness, confusion)
  • Weight gain
  • Injection site reactions (redness, swelling, lipodystrophy)
  • Hypokalemia (due to cellular potassium shift)

H. Adverse Effects & Toxicity

  • Severe hypoglycemia → Coma, seizures (requires IV dextrose or glucagon)
  • Insulin resistance → Leads to higher insulin requirements
  • Lipodystrophy → Fat loss or accumulation at injection sites

I. Role of the Nurse in Insulin Therapy

Before Administration

  • Check blood glucose levels.
  • Rotate injection sites to prevent lipodystrophy.
  • Ensure correct insulin type and dose.

During Administration

  • Use the correct insulin syringe (U-100, U-500).
  • Monitor for signs of hypoglycemia (shakiness, confusion, sweating).

After Administration

  • Educate on self-monitoring of blood glucose (SMBG).
  • Advise on diet and exercise.
  • Teach about hypoglycemia prevention (carry glucose tablets, avoid skipping meals).

3. Oral Hypoglycemics (Oral Antidiabetic Drugs)

A. Classification & Mechanism of Action

ClassExamplesMechanism of Action
BiguanidesMetforminReduces liver glucose production, increases insulin sensitivity
SulfonylureasGlimepiride, Glyburide, GlipizideStimulates pancreatic beta cells to release insulin
MeglitinidesRepaglinide, NateglinideIncreases insulin secretion (short-acting)
Thiazolidinediones (TZDs)Pioglitazone, RosiglitazoneIncreases insulin sensitivity in muscle and fat
DPP-4 InhibitorsSitagliptin, VildagliptinProlongs incretin hormone action, increasing insulin secretion
SGLT-2 InhibitorsCanagliflozin, DapagliflozinIncreases glucose excretion via urine
Alpha-Glucosidase InhibitorsAcarbose, MiglitolDelays carbohydrate absorption in intestines

B. Dosage & Route

  • Dosage: Individualized based on HbA1c levels and patient response.
  • Route: Oral (tablets or extended-release formulations).

C. Indications

  • Type 2 Diabetes Mellitus
  • Prediabetes (Metformin)
  • Polycystic Ovarian Syndrome (PCOS) (Metformin)

D. Contraindications

Drug ClassContraindications
MetforminRenal failure (GFR <30), lactic acidosis risk
SulfonylureasSevere liver/kidney disease
TZDsHeart failure, bladder cancer
SGLT-2 InhibitorsSevere kidney disease

E. Drug Interactions

Oral HypoglycemicInteracting DrugEffect
MetforminContrast agents (iodine)Lactic acidosis risk
SulfonylureasNSAIDs, AlcoholIncreased hypoglycemia risk
TZDsInsulinIncreased heart failure risk
SGLT-2 InhibitorsDiureticsDehydration, hypotension

F. Side Effects

Drug ClassCommon Side Effects
MetforminNausea, diarrhea, lactic acidosis (rare)
SulfonylureasHypoglycemia, weight gain
TZDsFluid retention, weight gain
DPP-4 InhibitorsNasopharyngitis, pancreatitis
SGLT-2 InhibitorsUTI, dehydration, ketoacidosis
Alpha-Glucosidase InhibitorsFlatulence, diarrhea

G. Adverse Effects & Toxicity

  • Metformin Toxicity: Lactic acidosis (treated with sodium bicarbonate & dialysis).
  • Sulfonylurea Overdose: Severe hypoglycemia (treated with IV dextrose).
  • TZDs: Risk of heart failure & bone fractures.

H. Role of the Nurse in Oral Hypoglycemics

Before Administration

  • Check renal & liver function (Metformin, TZDs).
  • Assess for hypoglycemia risk.

During Administration

  • Give with food (Sulfonylureas) to prevent hypoglycemia.
  • Monitor for GI symptoms (Metformin).

After Administration

  • Teach lifestyle modifications (exercise, diet).
  • Advise on self-monitoring of glucose levels.
  • Educate on hypoglycemia symptoms & management.

Thyroid and Anti-Thyroid Drugs:

1. Introduction

Thyroid hormones regulate metabolism, growth, energy production, and organ function. Thyroid disorders occur due to excessive (hyperthyroidism) or insufficient (hypothyroidism) hormone levels. Medications are used to replace deficient hormones or suppress overactive thyroid function.


2. Thyroid Hormones (For Hypothyroidism)

A. Composition of Thyroid Hormones

DrugComposition
Levothyroxine (T4)Synthetic Thyroxine (T4)
Liothyronine (T3)Synthetic Triiodothyronine (T3)
Desiccated Thyroid (Armour Thyroid)Animal-derived T3 & T4 mix

B. Mechanism of Action

  • Levothyroxine (T4): Converts to T3 (active form) in the body, replacing deficient thyroid hormone.
  • Liothyronine (T3): Directly provides active thyroid hormone for rapid action.

C. Dosage & Route

DrugDosageRoute
Levothyroxine25-200 mcg/dayOral, IV (for myxedema coma)
Liothyronine5-25 mcg/dayOral, IV
Desiccated Thyroid15-120 mg/dayOral

D. Indications

  • Hypothyroidism (Primary & Secondary)
  • Congenital Hypothyroidism (Cretinism)
  • Myxedema Coma (Severe hypothyroidism)
  • Goiter (due to iodine deficiency)
  • Post-Thyroidectomy Hormone Replacement

E. Contraindications

  • Untreated adrenal insufficiency
  • Thyrotoxicosis
  • Recent myocardial infarction
  • Hyperthyroidism (unless adjusting dose for treatment)

F. Drug Interactions

Interacting DrugEffect
Iron, Calcium, AntacidsReduce absorption
WarfarinIncreases anticoagulant effect
Beta-BlockersReduces effectiveness
Oral HypoglycemicsMay require dose adjustment

G. Side Effects

  • Insomnia, weight loss, tremors
  • Palpitations, tachycardia
  • Heat intolerance, sweating
  • Nervousness, anxiety

H. Adverse Effects & Toxicity

  • Hyperthyroidism-like symptoms (thyrotoxicosis)
  • Atrial fibrillation, osteoporosis (long-term use)
  • Acute overdose: Thyroid storm (requires beta-blockers, IV fluids)

I. Role of the Nurse in Thyroid Hormone Therapy

Before Administration

  • Check TSH, T3, T4 levels.
  • Assess heart rate and BP.
  • Give on an empty stomach (morning, 30 min before food).

During Administration

  • Monitor for overdose symptoms (palpitations, weight loss).
  • Adjust dose gradually.

After Administration

  • Educate on lifelong therapy.
  • Avoid abrupt discontinuation.
  • Monitor for signs of effectiveness (improved energy, stable weight, normal HR).

3. Anti-Thyroid Drugs (For Hyperthyroidism)

A. Composition of Anti-Thyroid Drugs

DrugComposition
Methimazole (MMI)Thioamide derivative
Propylthiouracil (PTU)Thioamide derivative
Radioactive Iodine (I-131)Radioactive isotope
Beta-Blockers (Propranolol, Atenolol)Non-selective β-blockers for symptom control

B. Mechanism of Action

  • Methimazole (MMI) & Propylthiouracil (PTU): Inhibit thyroid peroxidase, preventing thyroid hormone synthesis.
  • Radioactive Iodine (I-131): Destroys thyroid cells, reducing hormone production.
  • Beta-Blockers: Control symptoms (tachycardia, tremors) but do not reduce hormone levels.

C. Dosage & Route

DrugDosageRoute
Methimazole5-30 mg/dayOral
Propylthiouracil (PTU)50-150 mg 3x/dayOral
Radioactive Iodine (I-131)4-10 mCi single doseOral (capsule/liquid)
Propranolol10-40 mg every 6-8 hrsOral, IV (severe cases)

D. Indications

  • Hyperthyroidism (Graves’ Disease)
  • Toxic Multinodular Goiter
  • Thyroid Storm (PTU preferred)
  • Pre-surgery for Thyroidectomy
  • Thyroid Cancer (Radioactive Iodine)

E. Contraindications

  • Pregnancy (Methimazole is teratogenic; PTU preferred in 1st trimester)
  • Severe liver disease (PTU)
  • Hypothyroidism

F. Drug Interactions

Interacting DrugEffect
WarfarinIncreased bleeding risk
DigoxinIncreased levels due to slower metabolism
Beta-BlockersEnhanced effect in hyperthyroid patients

G. Side Effects

  • Methimazole/PTU:
    • Skin rash, nausea
    • Joint pain, headache
  • Radioactive Iodine:
    • Mild sore throat, dry mouth
    • Hypothyroidism (may require levothyroxine)
  • Beta-Blockers:
    • Fatigue, dizziness, bradycardia

H. Adverse Effects & Toxicity

  • Agranulocytosis (low WBCs, life-threatening infections)
  • Hepatotoxicity (PTU)
  • Thyroid Storm (if untreated)
    • Symptoms: Fever, tachycardia, confusion, seizures
    • Treatment: PTU, Beta-blockers, IV fluids, steroids

I. Role of the Nurse in Anti-Thyroid Therapy

Before Administration

  • Assess WBC count (risk of agranulocytosis).
  • Monitor liver function (PTU risk).
  • Check for pregnancy (avoid Methimazole in 1st trimester).

During Administration

  • Give Methimazole once daily; PTU multiple times daily.
  • Monitor for infection signs (fever, sore throat).
  • Ensure radiation precautions if using I-131.

After Administration

  • Monitor thyroid function (TSH, T3, T4).
  • Educate on agranulocytosis signs (fever, sore throat).
  • Advise on lifelong monitoring (radioactive iodine patients may develop hypothyroidism).

Steroids: Corticosteroids & Anabolic Steroids

1. Introduction

Steroids are a class of drugs used for various medical conditions. They are divided into:

  1. Corticosteroids – Used to reduce inflammation and suppress the immune system.
  2. Anabolic Steroids – Used to enhance muscle growth and treat conditions like testosterone deficiency.

CORTICOSTEROIDS

2. Corticosteroids

A. Composition of Corticosteroids

Corticosteroids are synthetic drugs that mimic hormones produced by the adrenal glands. They are classified into:

  • Glucocorticoids: Affect metabolism and immune response.
  • Mineralocorticoids: Regulate salt and water balance.
TypeExamplesMain Effects
GlucocorticoidsPrednisone, Dexamethasone, HydrocortisoneAnti-inflammatory, immunosuppressive
MineralocorticoidsFludrocortisoneRegulates sodium and water balance

B. Mechanism of Action

  • Glucocorticoids: Bind to intracellular receptors, regulating gene transcription to reduce inflammation, suppress immunity, and alter metabolism.
  • Mineralocorticoids: Increase sodium and water retention, helping regulate blood pressure and fluid balance.

C. Dosage & Route

DrugDosageRoute
Prednisone5-60 mg/dayOral
Dexamethasone0.5-10 mg/dayOral, IV, IM
Hydrocortisone20-100 mg/dayIV, Topical, Oral
Fludrocortisone0.05-0.2 mg/dayOral

D. Indications

  • Autoimmune Diseases (Rheumatoid arthritis, Lupus)
  • Allergic Reactions (Anaphylaxis, Asthma)
  • Inflammatory Disorders (IBD, COPD, Psoriasis)
  • Endocrine Disorders (Adrenal insufficiency – Addison’s Disease)
  • Cancer Treatment (Leukemia, Lymphoma)
  • Shock Management (Septic Shock, Adrenal Crisis)

E. Contraindications

  • Active infections (e.g., tuberculosis, fungal infections)
  • Uncontrolled diabetes mellitus
  • Severe osteoporosis
  • Glaucoma
  • Peptic ulcer disease

F. Drug Interactions

Interacting DrugEffect
NSAIDs (Aspirin, Ibuprofen)Increased risk of GI bleeding
DiureticsIncreased potassium loss (hypokalemia)
Insulin & Oral HypoglycemicsReduced effectiveness, causing hyperglycemia
WarfarinAlters anticoagulant effect

G. Side Effects

Short-TermLong-Term (Chronic Use)
HyperglycemiaOsteoporosis
HypertensionCushing’s Syndrome (moon face, buffalo hump)
Mood changesGrowth suppression (children)
InsomniaCataracts, Glaucoma

H. Adverse Effects & Toxicity

  • Cushingoid Appearance (Fat redistribution, weight gain, acne)
  • Adrenal Suppression (Long-term use suppresses natural cortisol production)
  • Osteoporosis (Bone loss, fractures)
  • Hyperglycemia & Diabetes
  • Steroid Withdrawal Syndrome (Fatigue, nausea, low BP after sudden stopping)

🔹 Management of Toxicity:

  • Gradual tapering (prevent adrenal insufficiency)
  • Monitor blood glucose & electrolytes
  • Calcium & Vitamin D supplements (prevent osteoporosis)

I. Role of the Nurse in Corticosteroid Therapy

Before Administration

  • Check baseline blood sugar, BP, weight, and bone density.
  • Assess for infection risk.

During Administration

  • Administer in the morning (mimic natural cortisol rhythm).
  • Take with food to reduce gastric irritation.

After Administration

  • Monitor for Cushing’s syndrome signs (moon face, hypertension).
  • Educate patients on gradual dose tapering.
  • Advise lifestyle changes (calcium-rich diet, exercise).

ANABOLIC STEROIDS

3. Anabolic Steroids

A. Composition of Anabolic Steroids

Anabolic steroids are synthetic derivatives of testosterone, used to enhance muscle growth, strength, and performance.

DrugComposition
TestosteroneSynthetic androgen
NandroloneInjectable anabolic steroid
OxandroloneOral anabolic steroid
StanozololPerformance-enhancing steroid

B. Mechanism of Action

  • Bind to androgen receptors, stimulating protein synthesis.
  • Increase red blood cell production (enhanced oxygen delivery).
  • Promote muscle and bone growth.

C. Dosage & Route

DrugDosageRoute
Testosterone50-200 mg every 2-4 weeksIM, Topical
Nandrolone25-100 mg/weekIM
Oxandrolone2.5-20 mg/dayOral
Stanozolol2-10 mg/dayOral, IM

D. Indications

  • Hypogonadism (Testosterone deficiency)
  • Delayed Puberty
  • Muscle Wasting Disorders (HIV/AIDS, Cancer)
  • Anemia (Stimulates RBC production)
  • Severe Burns (Muscle regeneration)

E. Contraindications

  • Prostate & Breast Cancer
  • Pregnancy
  • Severe Liver or Kidney Disease
  • Heart Disease & Hypertension

F. Drug Interactions

Interacting DrugEffect
WarfarinIncreased bleeding risk
InsulinEnhanced hypoglycemia
CorticosteroidsIncreased fluid retention
NSAIDsIncreased cardiovascular risk

G. Side Effects

MenWomenBoth
Testicular shrinkageDeep voiceLiver toxicity
BaldnessExcess body hairAcne
InfertilityIrregular periodsHigh cholesterol
Gynecomastia (breast enlargement)Clitoral enlargementAggressive behavior

H. Adverse Effects & Toxicity

  • Liver Damage (Hepatotoxicity)
  • Heart Disease (High LDL, Low HDL)
  • Psychological Effects (“Roid Rage”)
  • Severe Acne & Hair Loss
  • Blood Clots & Stroke

🔹 Management of Toxicity:

  • Liver function monitoring
  • Psychiatric evaluation for aggression
  • Hormonal therapy for withdrawal symptoms

I. Role of the Nurse in Anabolic Steroid Therapy

Before Administration

  • Assess testosterone levels before prescribing.
  • Screen for cardiovascular risks.

During Administration

  • Rotate injection sites for IM administration.
  • Monitor for mood changes & aggression.

After Administration

  • Educate on long-term risks (heart disease, infertility).
  • Encourage natural muscle-building methods (exercise, diet).
  • Monitor lipid profile & liver function regularly.

Calcitonin, Parathormone, Vitamin D3, and Calcium Metabolism.

1. Introduction

The calcium metabolism system regulates blood calcium levels through the interaction of hormones (calcitonin & parathormone), vitamin D3, and calcium salts. These components are essential for bone health, nerve conduction, muscle contraction, and blood clotting.

  • Calcitonin lowers calcium levels by inhibiting bone resorption.
  • Parathyroid Hormone (PTH) increases calcium levels by stimulating bone resorption, enhancing intestinal absorption, and reducing renal excretion.
  • Vitamin D3 (Cholecalciferol) promotes calcium absorption in the intestines.
  • Calcium salts are used for calcium supplementation.

2. Calcitonin

A. Composition of Calcitonin

DrugComposition
Calcitonin-SalmonSynthetic salmon calcitonin
Human CalcitoninRecombinant human calcitonin

B. Mechanism of Action

  • Inhibits osteoclast activity, reducing bone resorption.
  • Increases calcium excretion by kidneys, lowering serum calcium levels.

C. Dosage & Route

DrugDosageRoute
Calcitonin-Salmon50-100 IU/daySC, IM, Nasal Spray
Human Calcitonin0.5-1 mg/daySC, IV

D. Indications

  • Hypercalcemia
  • Osteoporosis
  • Paget’s Disease
  • Bone pain from metastatic cancer

E. Contraindications

  • Hypocalcemia
  • Allergy to calcitonin
  • Pregnancy & breastfeeding

F. Drug Interactions

Interacting DrugEffect
BisphosphonatesEnhanced effect in osteoporosis
Loop DiureticsIncreased calcium loss
LithiumDecreased lithium effectiveness

G. Side Effects

  • Nausea, vomiting
  • Flushing of the face
  • Hypocalcemia (muscle cramps, tingling)
  • Nasal irritation (with nasal spray)

H. Adverse Effects & Toxicity

  • Severe hypocalcemia (tetany, muscle spasms)
  • Allergic reactions (anaphylaxis)
  • Long-term nasal spray use → Nasal ulceration

🔹 Management of Toxicity:

  • Calcium & Vitamin D supplementation.
  • Discontinue drug if severe allergic reaction occurs.

I. Role of the Nurse in Calcitonin Therapy

Before Administration

  • Check serum calcium levels.
  • Assess for nasal irritation (if using nasal spray).

During Administration

  • Rotate injection sites (SC, IM).
  • Monitor for hypocalcemia symptoms.

After Administration

  • Educate patients on nasal spray use (alternate nostrils).
  • Encourage calcium-rich diet.

3. Parathyroid Hormone (Parathormone – PTH)

A. Composition of Parathyroid Hormone

DrugComposition
TeriparatideRecombinant human PTH (1-34)
NatparaFull-length recombinant PTH

B. Mechanism of Action

  • Stimulates osteoblasts, increasing bone formation.
  • Enhances calcium reabsorption in kidneys.
  • Increases intestinal calcium absorption via Vitamin D activation.

C. Dosage & Route

DrugDosageRoute
Teriparatide20 mcg/daySC
Natpara50-100 mcg/daySC

D. Indications

  • Osteoporosis (high fracture risk)
  • Hypoparathyroidism
  • Severe vitamin D-resistant rickets

E. Contraindications

  • Hypercalcemia
  • Paget’s disease
  • Bone cancer history

F. Drug Interactions

Interacting DrugEffect
DigoxinIncreased risk of toxicity
Loop DiureticsIncreased calcium loss

G. Side Effects

  • Dizziness, nausea
  • Hypercalcemia (kidney stones, constipation)
  • Leg cramps

H. Adverse Effects & Toxicity

  • Osteosarcoma risk (long-term use)
  • Severe hypercalcemia (confusion, arrhythmias)

🔹 Management of Toxicity:

  • Reduce calcium intake.
  • Monitor renal function.

I. Role of the Nurse in Parathormone Therapy

Before Administration

  • Assess calcium levels.
  • Check renal function.

During Administration

  • Administer SC in the thigh.
  • Monitor for dizziness (fall risk).

After Administration

  • Educate on daily SC injections.
  • Ensure adequate calcium intake.

4. Vitamin D3 (Cholecalciferol)

A. Composition of Vitamin D3

DrugComposition
CholecalciferolVitamin D3
ErgocalciferolVitamin D2
CalcitriolActive Vitamin D3

B. Mechanism of Action

  • Enhances calcium & phosphorus absorption in intestines.
  • Stimulates osteoblasts, improving bone formation.
  • Reduces PTH secretion in hyperparathyroidism.

C. Dosage & Route

DrugDosageRoute
Cholecalciferol400-1000 IU/dayOral
Calcitriol0.25-1 mcg/dayOral, IV

D. Indications

  • Osteoporosis
  • Rickets (Children)
  • Hypoparathyroidism
  • Chronic kidney disease (CKD)

E. Contraindications

  • Hypercalcemia
  • Vitamin D toxicity
  • Kidney stones

F. Drug Interactions

Interacting DrugEffect
Thiazide DiureticsIncreased hypercalcemia risk
CorticosteroidsReduced Vitamin D effect

G. Side Effects

  • Nausea, vomiting
  • Constipation
  • Muscle weakness

H. Adverse Effects & Toxicity

  • Hypercalcemia (kidney stones, confusion, arrhythmias)
  • Vitamin D toxicity (excessive thirst, polyuria)

🔹 Management of Toxicity:

  • Stop Vitamin D intake.
  • Increase fluid intake.

I. Role of the Nurse in Vitamin D Therapy

Before Administration

  • Assess calcium levels.
  • Ensure no kidney stone history.

During Administration

  • Give with food for better absorption.

After Administration

  • Educate on sunlight exposure for natural Vitamin D.
  • Monitor calcium intake.

5. Calcium Salts

A. Types of Calcium Salts

Calcium SupplementElemental Calcium Content
Calcium Carbonate40%
Calcium Citrate21%
Calcium Gluconate9%

B. Indications

  • Osteoporosis prevention
  • Hypocalcemia
  • Hyperkalemia (Calcium Gluconate IV)

C. Adverse Effects

  • Constipation
  • Hypercalcemia (kidney stones, confusion)

🔹 Management:

  • Hydration & dietary balance.

Role and Responsibilities of Nurses in the Administration of Drugs for Endocrine System Disorders

1. Introduction

The endocrine system regulates metabolism, growth, development, and homeostasis through hormones. Disorders such as diabetes, hypothyroidism, hyperthyroidism, adrenal dysfunction, osteoporosis, and calcium imbalances require pharmacological intervention. Nurses play a crucial role in safe drug administration, patient education, monitoring therapy, and preventing complications.


2. Drugs Used for Endocrine Disorders & Nursing Responsibilities

Endocrine DisorderDrug ClassExamples
Diabetes MellitusInsulin, Oral HypoglycemicsInsulin, Metformin, Glipizide, Dapagliflozin
HypothyroidismThyroid HormonesLevothyroxine, Liothyronine
HyperthyroidismAnti-Thyroid DrugsMethimazole, Propylthiouracil
Adrenal Insufficiency (Addison’s Disease)Glucocorticoids & MineralocorticoidsPrednisone, Hydrocortisone, Fludrocortisone
Cushing’s SyndromeCortisol InhibitorsKetoconazole, Metyrapone
OsteoporosisBisphosphonates, CalcitoninAlendronate, Risedronate, Calcitonin
Calcium DisordersCalcium & Vitamin D, PTH AnaloguesCalcium Gluconate, Calcitriol, Teriparatide

3. Nursing Responsibilities in Endocrine Drug Administration

Nurses have multiple roles in ensuring safe and effective medication therapy for endocrine disorders.

A. Before Administration

Assess Baseline Data

  • Vital signs (BP, HR for thyroid & adrenal drugs)
  • Blood glucose levels (for insulin & oral hypoglycemics)
  • Electrolyte levels (for calcium, potassium, sodium imbalances)
  • Thyroid function tests (TSH, T3, T4)
  • Adrenal function tests (ACTH, cortisol levels)

Check for Contraindications

  • Avoid insulin overdose in hypoglycemic patients.
  • Monitor for liver dysfunction before prescribing Metformin.
  • Check renal function before giving bisphosphonates or SGLT2 inhibitors.

Confirm Correct Drug, Dose & Route

  • Insulin: Ensure correct type (rapid, short, intermediate, long-acting).
  • Thyroid hormones: Administer Levothyroxine on an empty stomach.
  • Calcium supplements: Give Calcium Citrate for patients with low stomach acid.

Educate the Patient

  • Diabetic patients: Teach how to self-monitor blood glucose (SMBG).
  • Hypothyroidism patients: Advise lifelong therapy adherence.
  • Osteoporosis patients: Instruct on posture while taking bisphosphonates (stay upright for 30 minutes to prevent esophageal irritation).

B. During Administration

Monitor for Drug Reactions

  • Hypoglycemia (for Insulin & Sulfonylureas): Sweating, dizziness, confusion.
  • Thyroid Hormone Overdose: Palpitations, insomnia, weight loss.
  • Glucocorticoid Side Effects: Hyperglycemia, mood changes, Cushing’s syndrome.

Ensure Proper Drug Administration Techniques

  • Insulin Injection: Rotate injection sites to prevent lipodystrophy.
  • Oral Bisphosphonates: Take with water on an empty stomach; remain upright.
  • IV Calcium: Administer slowly to prevent arrhythmias.

Monitor Blood Levels

  • Diabetes drugs: Check HbA1c every 3 months.
  • Thyroid medications: Adjust dose based on TSH & T4 levels.
  • Adrenal drugs: Monitor cortisol levels & electrolytes.

C. After Administration

Evaluate Drug Effectiveness

  • Diabetes: Check improved blood glucose control (FBS <126 mg/dL).
  • Hypothyroidism: Assess energy levels, weight normalization, HR stabilization.
  • Osteoporosis: Monitor bone density scans (DEXA scans).

Manage Side Effects

  • Steroids: Educate about infection risk & osteoporosis prevention.
  • Antithyroid drugs: Monitor for agranulocytosis (fever, sore throat).
  • SGLT2 inhibitors: Monitor for UTIs & dehydration.

Educate Patients for Long-Term Management

  • Diabetic patients: Maintain diet, exercise, foot care.
  • Thyroid patients: Take medications consistently at the same time.
  • Osteoporosis patients: Increase calcium intake & weight-bearing exercises.

4. Emergency Management in Endocrine Drug Therapy

ComplicationEmergency DrugNursing Actions
Severe Hypoglycemia (from Insulin or Sulfonylureas)IV Dextrose, GlucagonCheck blood glucose, administer dextrose, monitor vitals
Thyroid Storm (from Hyperthyroidism)Beta-blockers, PTU, CorticosteroidsMonitor HR & BP, provide oxygen, IV fluids
Adrenal Crisis (from Steroid Withdrawal)IV Hydrocortisone, IV FluidsMonitor BP, replace fluids, provide emergency corticosteroids
Hypercalcemia (from Overdose of Calcium/Vitamin D3)IV Fluids, Diuretics, CalcitoninHydration therapy, monitor ECG

Published
Categorized as BSC - SEM 3 - PHARMACOLOGY, Uncategorised